Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Black Hawk Acquisition
Acquired Company
Vesicor Therapeutics
CaliforniaSan GabrielBiotechnologyBiotechnologyDescription
On October 13, 2026, Black Hawk Acquisition Corporation announced shareholder approval for its merger with Vesicor Therapeutics, Inc. The merger involves significant business combinations and was supported by a majority vote at the extraordinary general meeting. Shareholders also approved various corporate proposals, including a shift of the company’s domicile to Delaware. Following the merger, new directors have been elected to the board.
Fundz sees it the moment Black Hawk Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Vesicor Therapeutics?
Vesicor Therapeutics was acquired by Black Hawk Acquisition, based in California. The deal was reported on October 13, 2026. Black Hawk Acquisition Corp is a special purpose acquisition company (SPAC) focused on acquiring and merging with high-potential businesses. The company is currently working on completing a business combination. Black Hawk Acquisition is publicly traded (BKHA) and operates in Biotechnology.
When did Black Hawk Acquisition acquire Vesicor Therapeutics?
Black Hawk Acquisition's acquisition of Vesicor Therapeutics was reported on October 13, 2026. On October 13, 2026, Black Hawk Acquisition Corporation announced shareholder approval for its merger with Vesicor Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vesicor Therapeutics do?
Vesicor Therapeutics is the company acquired in this transaction. It is privately held, operating in Biotechnology, and is based in San Gabriel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.